Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders
Overview
Chemistry
Molecular Biology
Authors
Affiliations
Damage-associated molecular patterns (DAMPs) are endogenous danger molecules released from the extracellular and intracellular space of damaged tissue or dead cells. Recent evidence indicates that DAMPs are associated with the sterile inflammation caused by aging, increased ocular pressure, high glucose, oxidative stress, ischemia, mechanical trauma, stress, or environmental conditions, in retinal diseases. DAMPs activate the innate immune system, suggesting their role to be protective, but may promote pathological inflammation and angiogenesis in response to the chronic insult or injury. DAMPs are recognized by specialized innate immune receptors, such as receptors for advanced glycation end products (RAGE), toll-like receptors (TLRs) and the NOD-like receptor family (NLRs), and purine receptor 7 (P2X7), in systemic diseases. However, studies describing the role of DAMPs in retinal disorders are meager. Here, we extensively reviewed the role of DAMPs in retinal disorders, including endophthalmitis, uveitis, glaucoma, ocular cancer, ischemic retinopathies, diabetic retinopathy, age-related macular degeneration, rhegmatogenous retinal detachment, proliferative vitreoretinopathy, and inherited retinal disorders. Finally, we discussed DAMPs as biomarkers, therapeutic targets, and therapeutic agents for retinal disorders.
Role of Microglia in Glaucomatous Pathology.
Somerville M, Garner M, Girkin C, Gross A Adv Exp Med Biol. 2025; 1468:149-153.
PMID: 39930188 DOI: 10.1007/978-3-031-76550-6_25.
Moulin C, Dvoriantchikova G, Bineshfar N, Swingle B, Martinez G, Groso D Res Sq. 2024; .
PMID: 39574891 PMC: 11581122. DOI: 10.21203/rs.3.rs-5085599/v1.
Eye on the horizon: The metabolic landscape of the RPE in aging and disease.
Hansman D, Du J, Casson R, Peet D Prog Retin Eye Res. 2024; 104:101306.
PMID: 39433211 PMC: 11833275. DOI: 10.1016/j.preteyeres.2024.101306.
Risk factors for endogenous endophthalmitis in infectious endocarditis patients.
Shah M, Zhu A, Uppuluri A, Henry R, Zarbin M, Bhagat N Eye (Lond). 2024; 39(1):125-132.
PMID: 39402169 PMC: 11733160. DOI: 10.1038/s41433-024-03390-w.
Livingston A, Purves J, Odom M, Jin H, Hughes Jr F Continence (Amst). 2024; 12.
PMID: 39399064 PMC: 11466384. DOI: 10.1016/j.cont.2024.101690.